Supplement's IBS Treatment Claim Fails UK Review Following J&J Ltd. Complaint
This article was originally published in The Pink Sheet
Executive Summary
EnteroMed fails to provide adequate support for ad claims that its supplement gel absorbs toxins and treats gastrointestinal issues, including IBS, the UK Advertising Standards Authority says. A J&J UK subsidiary marketing competing consumer health products was among the complainants about the firm's ads.
You may also be interested in...
Health & Wellness Industry News Roundup: Week Of Aug. 1
Kratom seized again; FTC warns on Zika claims; EntereoMed passes 2 of 3 UK gut health claim checks; Bevolution adds Dr. Smoothie to lineup; physicians committee recommends prebiotics; and more news in brief.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.